Specialty Chemicals company Camlin Fine Sciences announced Q1FY27 results Consolidated Financial Highlights: Revenue from Operations: The consolidated revenue from operations for Q1FY27 stood at Rs 5,198.79 million, representing a growth of 27.51% YoY from Rs 4,077.21 million in Q1FY26 and an increase of 22.38% QoQ from Rs 4,248.11 million in Q4FY26. Total Income: Total income for the quarter reached Rs 5,212.19 million in Q1FY27, compared to Rs 4,143.48 million in Q1FY26 and Rs 4,487.23 million in Q4FY26. Net Profit/(Loss): The group reported a consolidated net loss for the period of Rs 336.22 million in Q1FY27, as against a net profit of Rs 862.77 million in Q4FY26 and a net loss of Rs 106.81 million in Q1FY26. Total Comprehensive Income: Total comprehensive loss for Q1FY27 was Rs 163.62 million, compared to a comprehensive income of Rs 12.48 million in Q1FY26 and Rs 743.85 million in Q4FY26. Earnings Per Share (EPS): The basic and diluted EPS for Q1FY27 stood at negative Rs 1.65. Standalone Financial Highlights: Revenue from Operations: Standalone revenue from operations for Q1FY27 was Rs 2,224.86 million, up 16.22% YoY from Rs 1,914.38 million in Q1FY26 and up 21.23% QoQ from Rs 1,835.17 million in Q4FY26. Total Income: Total standalone income stood at Rs 2,238.88 million in Q1FY27, compared to Rs 1,951.27 million in Q1FY26. Net Profit/(Loss): The company recorded a standalone net loss of Rs 123.12 million in Q1FY27, compared to a loss of Rs 106.81 million in Q1FY26 and a loss of Rs 56.49 million in Q4FY26. Total Comprehensive Income: Standalone total comprehensive loss for the quarter was Rs 86.28 million in Q1FY27, compared to a loss of Rs 104.56 million in Q1FY26 and Rs 66.42 million in Q4FY26. Business Highlights: Segment Performance: The group transitioned to reporting under three business segments starting from Q1FY27: Specialty Ingredients: Segment revenue reached Rs 4,013.17 million with segment results of Rs 254.66 million. Aroma: Segment revenue stood at Rs 774.07 million, with a segment loss of Rs 33.81 million. Performance Chemicals & Others: Segment revenue recorded at Rs 1,748.90 million, with a segment loss of Rs 44.41 million. Exceptional Items: The consolidated results include an exceptional expense of Rs 111.10 million. This primarily includes Rs 108.8 million representing the shortfall from an insurance claim settlement related to a fire incident on February 7, 2026, at a blending unit of CFS Do Brasil, a wholly-owned subsidiary. Vinpai S.A. Acquisition: Following an open offer that closed on July 6, 2026, the company increased its shareholding in Vinpai S.A. to 95.41% by acquiring an additional 501,842 equity shares for Rs 194.63 million. Operational Update (Dahej Unit): A fire incident occurred at the Diphenol manufacturing unit at Dahej on May 23, 2026. Management noted that the loss of machinery, inventories, and related expenses, totaling Rs 67.03 million, is entirely covered by insurance, and no residual loss is expected. Liquidation of Subsidiary: The liquidation process for CFS Europe SpA (an erstwhile wholly-owned subsidiary) is ongoing. Assets and liabilities were de-recognized effective March 17, 2026, and legal expenses of Rs 2.50 million were incurred during the current quarter. Employee Stock Options: During Q1FY27, no employee stock options were issued or allotted. A total of 80,000 options lapsed under ESOP 2021 and were returned to the option pool. Result PDF